These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12763214)

  • 1. Development of an EORTC disease-specific quality of life questionnaire for use in patients with liver metastases from colorectal cancer.
    Kavadas V; Blazeby JM; Conroy T; Sezer O; Holzner B; Koller M; Buckels J;
    Eur J Cancer; 2003 Jun; 39(9):1259-63. PubMed ID: 12763214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer.
    Vickery CW; Blazeby JM; Conroy T; Arraras J; Sezer O; Koller M; Rosemeyer D; Johnson CD; Alderson D;
    Eur J Cancer; 2001 May; 37(8):966-71. PubMed ID: 11334720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study to validate the Polish language version of the European Organisation for Research and Treatment of Cancer (EORTC) Colorectal Liver Metastases (QLQ-LMC21) module.
    Paradowska D; Bereza K; Sanna B; Kucharska E; Tomaszewska IM; Dudkiewicz Z; Skotnicki P; Bottomley A; Tomaszewski KA
    Eur J Oncol Nurs; 2017 Aug; 29():148-154. PubMed ID: 28578847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21.
    Friend E; Yadegarfar G; Byrne C; Johnson CD; Sezer O; Pucciarelli S; Pereira SP; Chie WC; Banfield A; Ramage JK;
    Br J Cancer; 2011 Feb; 104(4):587-92. PubMed ID: 21266979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the European Organization for Research and Treatment of Cancer QLQ-LMC21 questionnaire for assessment of patient-reported outcomes during treatment of colorectal liver metastases.
    Blazeby JM; Fayers P; Conroy T; Sezer O; Ramage J; Rees M;
    Br J Surg; 2009 Mar; 96(3):291-8. PubMed ID: 19224519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: The EORTC QLQ-ELD15.
    Johnson C; Fitzsimmons D; Gilbert J; Arrarras JI; Hammerlid E; Bredart A; Ozmen M; Dilektasli E; Coolbrandt A; Kenis C; Young T; Chow E; Venkitaraman R; Howse F; George S; O'Connor S; Yadegarfar G;
    Eur J Cancer; 2010 Aug; 46(12):2242-52. PubMed ID: 20580993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
    Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB
    Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18.
    Blazeby JM; Currie E; Zee BC; Chie WC; Poon RT; Garden OJ;
    Eur J Cancer; 2004 Nov; 40(16):2439-44. PubMed ID: 15519517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life.
    Sprangers MA; te Velde A; Aaronson NK
    Eur J Cancer; 1999 Feb; 35(2):238-47. PubMed ID: 10448266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life.
    Fitzsimmons D; Johnson CD; George S; Payne S; Sandberg AA; Bassi C; Beger HG; Birk D; Büchler MW; Dervenis C; Fernandez Cruz L; Friess H; Grahm AL; Jeekel J; Laugier R; Meyer D; Singer MW; Tihanyi T
    Eur J Cancer; 1999 Jun; 35(6):939-41. PubMed ID: 10533475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I-III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer.
    Sodergren SC; Johnson CD; Gilbert A; Tomaszewski KA; Chu W; Chung HT; Dennis K; Desideri I; Glynne-Jones R; Grønlie Guren M; Kardamakis D; Nugent K; Schmidt H; Sebag-Montefiore D; Vassiliou V;
    Radiother Oncol; 2018 Feb; 126(2):222-228. PubMed ID: 29217122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life.
    Bergman B; Aaronson NK; Ahmedzai S; Kaasa S; Sullivan M
    Eur J Cancer; 1994; 30A(5):635-42. PubMed ID: 8080679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22.
    Chow E; Hird A; Velikova G; Johnson C; Dewolf L; Bezjak A; Wu J; Shafiq J; Sezer O; Kardamakis D; van der Linden Y; Ma B; Castro M; Arnalot PF; Ahmedzai S; Clemons M; Hoskin P; Yee A; Brundage M; Bottomley A;
    Eur J Cancer; 2009 May; 45(7):1146-1152. PubMed ID: 19097882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an EORTC module to improve quality of life assessment in patients with gastric cancer.
    Vickery CW; Blazeby JM; Conroy T; Johnson CD; Alderson D
    Br J Surg; 2000 Mar; 87(3):362-73. PubMed ID: 10718972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group.
    Blazeby JM; Alderson D; Winstone K; Steyn R; Hammerlid E; Arraras J; Farndon JR
    Eur J Cancer; 1996 Oct; 32A(11):1912-7. PubMed ID: 8943674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EORTC ophthalmic oncology quality of life questionnaire module (EORTC QLQ-OPT30). Development and pre-testing (Phase I-III).
    Brandberg Y; Damato B; Kivelä T; Kock E; Seregard S; ;
    Eye (Lond); 2004 Mar; 18(3):283-9. PubMed ID: 15004578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation.
    Velikova G; Weis J; Hjermstad MJ; Kopp M; Morris P; Watson M; Sezer O;
    Eur J Cancer; 2007 Jan; 43(1):87-94. PubMed ID: 17081744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. EORTC Quality of Life Study Group.
    Sprangers MA; Cull A; Groenvold M; Bjordal K; Blazeby J; Aaronson NK
    Qual Life Res; 1998 May; 7(4):291-300. PubMed ID: 9610213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of Life.
    Stead ML; Brown JM; Velikova G; Kaasa S; Wisløff F; Child JA; Hippe E; Hjorth M; Sezer O; Selby P
    Br J Haematol; 1999 Mar; 104(3):605-11. PubMed ID: 10086801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a European Organization for Research and Treatment of Cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report.
    Cull A; Howat S; Greimel E; Waldenstrom AC; Arraras J; Kudelka A; Chauvenet L; Gould A; ;
    Eur J Cancer; 2001 Jan; 37(1):47-53. PubMed ID: 11165129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.